3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
112
Breast Neoplasms
17
Neoplasms
7
Leiomyoma
6
Prostate Adenocarcinoma
3
Polycystic Ovary Syndrome
3
Salivary Gland Neoplasms
2
Neoplasm Metastasis
2
Multiple Myeloma
2
Lymphoma, Non-Hodgkin
2
Uveal Melanoma
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Sleep Apnea, Obstructive
1
Skin Neoplasms
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Salivary Gland Neoplasm Duct
1
Recurrence
1
Puberty, Precocious
1
Primary Dysautonomias
1
Premenopausal Breast Cancer
1
Patient Compliance
1
PSA Level Greater Than Two
1
Obesity, Morbid
1
Obesity
1
Myofibroma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Metabolic Syndrome
1
Melanoma
1
Interventions
Nutrition Assessment
2
Blood Specimen Collection
2
spartalizumab
1
pembrolizumab
1
etelcalcetide hydrochloride
1
enzalutamide
1
bicalutamide
1
aldesleukin
1
Valsartan
1
Stents
1
Specimen Handling
1
Sorafenib
1
Sodium Bicarbonate
1
Resistance Training
1
Receptors, Androgen
1
Nephrotomy
1
Nephrostomy, Percutaneous
1
Lysine Acetyltransferase 5
1
Leuprolide
1
Interleukin-2
1
Ice
1
Hydroxychloroquine
1
Health Information Exchange
1
Goserelin
1
Flutamide
1
Cisplatin
1
Adalimumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Kidney Diseases
×
Leuprolide
×
Clear all
NCT05700903
2026-03-02
ARCH
University of Colorado, Denver
Phase 4
Completed
10 enrolled